The L-C Ligament® is not available for sale in the EU or United States


About STR

Soft Tissue Regeneration is a medical device company dedicated to developing breakthrough technologies for regeneration of soft tissue. STR has devloped the L-C Ligament®, a bioresorbable scaffold for the reconstruction of the anterior cruciate ligament (“ACL”) of the knee.

Read More

In the News

Robert Stanton, MD, past AOSSM President and Managing Partner of Orthopaedic Specialty Group, PC, Fairfield, CT, presented pre-clinical research on the L-C Ligament® at the annual meeting of the American Orthopaedic Society for Sports Medicine in Orlando, FL.

Read More

For Patients

Learn more about the technologies we offer versus the current treatments for ACL Reconstruction Surgery, and our break through technology, the L-C Ligament®. Also see if you qualify for our European Clinical Trials.

Read More


Clinical Trials

CE Mark clinical trials set to start in Europe, 2nd Qtr. 2015.

First bioengineered ACL to completely regenerate.
Scientific Advisory Board

Our Advisory Board is comprised of world-renowned surgeons, professors and sports medicine experts.
Contact Us

Soft Tissue Regeneration wants to hear from you. Contact us to learn more.

Mailing List

If you are interested in learning more about Soft Tissue Regeneration join our mailing list for news and updates.

Back to Top
Enter your Infotext or Widgets here...